Alzheimer's disease & dementia

Big data initiative discovers new causal pathways in Alzheimer's

A new study, published on Feb. 15 in Alzheimer's & Dementia, analyzed biological samples from hundreds of individuals from a European study. Researchers looked at the biological information at various levels—genes, proteins, ...

Diseases, Conditions, Syndromes

A new class of antibodies against COVID-19 is being put to the test

A new class of SARS-CoV-2 antibodies has been shown to neutralize multiple variants of the virus, providing hope for a better antiviral medication to prevent and treat COVID-19 symptoms in at-risk individuals, according to ...

Diseases, Conditions, Syndromes

New standards to quantify hepatitis B virus reservoirs in liver cells

Approximately 300 million people are chronically infected with the hepatitis B virus (HBV), which can cause liver cirrhosis or cancer. Consequently, there is an urgent need for the development of HBV curative therapies. Due ...

Oncology & Cancer

Review covers progress in immunotherapy for esophageal cancer

Esophageal cancer (EC) is one of the most common types of cancer worldwide and was ranked as the sixth leading cause of cancer-related deaths in 2020. When EC is localized or locally advanced, referred to as resectable EC, ...

page 10 from 29